You are here

  • Home
  • Archive
  • Volume 80, Issue 3
  • Correspondence on ‘Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine’

Article info

Article menu
Download PDFPDF
Correspondence
Correspondence on ‘Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine’

Authors

  • Mandana Nikpour Department of Medicine at St Vincent's Hospital, University of Melbourne, Fitzroy, Victoria, Australia PubMed articlesGoogle scholar articles
  • Benjamin Teh Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Ian P Wicks Clinical Translation, The Walter and Eliza hall Institute of Medical Research, Parkville, Victoria, Australia Rheumatology Unit, Royal Melbourne Hospital, Melbourne, Victoria, Australia Department of Medical Biology, The University of Melbourne, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Marc Pellegrini Department of Medical Biology, The University of Melbourne, Melbourne, Victoria, Australia Infectious Diseases and Immune Defence, Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Mandana Nikpour, Department of Medicine, University of Melbourne, Fitzroy, VIC 3010, Australia; m.nikpour{at}unimelb.edu.au
View Full Text

Citation

Nikpour M, Teh B, Wicks IP, et al
Correspondence on ‘Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine’
Annals of the Rheumatic Diseases 2021;80:e33.

Publication history

  • Received May 1, 2020
  • Accepted May 4, 2020
  • First published May 29, 2020.
Online issue publication 
May 25, 2023

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage